HSDT — Helius Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $28.12m
- $27.03m
- $0.52m
Annual cashflow statement for Helius Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.1 | -18.1 | -14.1 | -8.85 | -11.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.93 | 4.3 | 0.813 | -1.42 | 0.649 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.02 | 0.127 | -1.31 | -0.311 | -0.008 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11.7 | -13.4 | -14.3 | -10.4 | -11 |
| Capital Expenditures | -0.07 | -0.056 | -0.017 | -0.029 | -0.005 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0.061 | 0 | 0.006 | 0 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.009 | -0.056 | -0.011 | -0.029 | -0.005 |
| Financing Cash Flow Items | -1.01 | -2.89 | -0.775 | -0.065 | -1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.64 | 21.1 | 17.9 | 1.08 | 6.95 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.13 | 7.67 | 3.54 | -9.37 | -4.09 |